BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22888646)

  • 1. [Molecular risk markers for malignant transformation of oral mucosal leukoplakia ].
    Skorodumova LO; Muriaev AA; Volodina EV; Ivanov SIu; Gnuchev NV; Georgiev GP; Larin SS
    Vopr Onkol; 2012; 58(3):327-32. PubMed ID: 22888646
    [No Abstract]   [Full Text] [Related]  

  • 2. [Keratin 8 expression in mouth mucosa hyperkeratosis and squamous cell carcinoma ].
    Babichenko II; Grigor'ian AS; Katushkina AA
    Arkh Patol; 2011; 73(6):18-21. PubMed ID: 22379894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
    Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
    Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
    Shintani S; Yoshihama Y; Emilio AR; Matsumura T
    Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relevance of EGFR overexpression for the prediction of the malignant transformation of oral leukoplakia.
    Ries J; Vairaktaris E; Agaimy A; Bechtold M; Gorecki P; Neukam FW; Nkenke E
    Oncol Rep; 2013 Sep; 30(3):1149-56. PubMed ID: 23784518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-phase fraction and DNA ploidy in oral leukoplakia.
    Khanna R; Agarwal A; Khanna S; Basu S; Khanna AK
    ANZ J Surg; 2010; 80(7-8):548-51. PubMed ID: 20795971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular markers of the risk of oral cancer.
    Lippman SM; Hong WK
    N Engl J Med; 2001 Apr; 344(17):1323-6. PubMed ID: 11320393
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
    Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
    Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of MAGE-A expression predicts malignant transformation of oral leukoplakia.
    Ries J; Agaimy A; Vairaktaris E; Gorecki P; Neukam FW; Strassburg LH; Nkenke E
    Cancer Invest; 2012 Aug; 30(7):495-502. PubMed ID: 22646284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.
    Nayak S; Goel MM; Makker A; Bhatia V; Chandra S; Kumar S; Agarwal SP
    PLoS One; 2015; 10(10):e0138801. PubMed ID: 26465941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of MAGE-A expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
    Ries J; Agaimy A; Vairaktaris E; Kwon Y; Neukam FW; Strassburg LH; Nkenke E
    Int J Oncol; 2012 Sep; 41(3):1085-93. PubMed ID: 22751922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The precancerous condition of the mouth mucosa. Advantage of early diagnosis].
    Sentilhes C; Mercure JL
    Rev Odontostomatol (Paris); 1982; 11(3):229-36. PubMed ID: 6957961
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased subepithelial vascularization and VEGF expression reveal potentially malignant changes in human oral mucosa lesions.
    Gandolfo M; Keszler A; Lanfranchi H; Itoiz ME
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Apr; 111(4):486-93. PubMed ID: 21420637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Leukoplakia and erythroplakia--two orale precursor lesions].
    Grajewski S; Groneberg D
    Laryngorhinootologie; 2009 Oct; 88(10):666-72; quiz 673-5. PubMed ID: 19813163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p27 and apoptosis in oral leukoplakia.
    Tsuzuki H; Fujieda S; Sunaga H; Narita N; Tokuriki M; Saito H
    Anticancer Res; 2003; 23(2B):1265-70. PubMed ID: 12820381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of TC21 overexpression in oral cancer.
    Macha MA; Matta A; Sriram U; Thakkar A; Shukla NK; Datta Gupta S; Ralhan R
    J Oral Pathol Med; 2010 Jul; 39(6):477-85. PubMed ID: 20040018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
    Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
    Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral medicine 8. Leukoplakia of the oral mucosa].
    Schepman KP; van der Meij EH; de Visscher JG
    Ned Tijdschr Tandheelkd; 2013; 120(7-8):384-90. PubMed ID: 23923441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders.
    Sperandio M; Brown AL; Lock C; Morgan PR; Coupland VH; Madden PB; Warnakulasuriya S; Møller H; Odell EW
    Cancer Prev Res (Phila); 2013 Aug; 6(8):822-31. PubMed ID: 23761273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentially Malignant Oral Disorders and Cancer Transformation.
    Ganesh D; Sreenivasan P; Öhman J; Wallström M; Braz-Silva PH; Giglio D; Kjeller G; Hasséus B
    Anticancer Res; 2018 Jun; 38(6):3223-3229. PubMed ID: 29848669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.